These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33582159)
1. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes. Madsen A; Krause J; Höppner G; Hirt MN; Tan WLW; Lim I; Hansen A; Nikolaev VO; Foo RSY; Eschenhagen T; Stenzig J J Mol Cell Cardiol; 2021 May; 154():115-123. PubMed ID: 33582159 [TBL] [Abstract][Full Text] [Related]
2. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility. Madsen A; Höppner G; Krause J; Hirt MN; Laufer SD; Schweizer M; Tan WLW; Mosqueira D; Anene-Nzelu CG; Lim I; Foo RSY; Hansen A; Eschenhagen T; Stenzig J Circulation; 2020 Oct; 142(16):1562-1578. PubMed ID: 32885664 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors. Stenzig J; Hirt MN; Löser A; Bartholdt LM; Hensel JT; Werner TR; Riemenschneider M; Indenbirken D; Guenther T; Müller C; Hübner N; Stoll M; Eschenhagen T Basic Res Cardiol; 2016 Jan; 111(1):9. PubMed ID: 26680771 [TBL] [Abstract][Full Text] [Related]